Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Treatment with MoodHeadBand (T-PEMF treatment) with placebo for people with Moderate Depression, Severe Depressive Episode Without Psychotic Symptoms, Recurrent depression, Current Episode Moderate, or Recurrent depression, Current Episode Severe Without Psychotic Symptoms. Participants receive Treatment with MoodHeadBand (T-PEMF treatment) or placebo and complete study visits and assessments.
This study is looking at whether cognitive behavioural therapy can help people with Depression or Antenatal Depression. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This study is comparing Psilocybin with placebo for people with depression. Participants receive Psilocybin or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.
This study is looking at evaluate how well esketamine nasal spray works in improving depressive symptoms in participants with treatment resistant depression (TRD) for people with depression, Treatment-Resistant. Taking part may give some people access to Esketamine 56 mg, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Mianserin can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Vortioxetine tablets with placebo for people with depression. Participants receive Vortioxetine tablets or placebo and complete study visits and assessments.
This study is testing whether CYB003, compared with placebo, is safe and helpful as an add-on treatment for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.
This observational study is following people with Postpartum Depression or Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Icalcaprant with placebo for people with depression. Participants receive Icalcaprant or placebo and complete study visits and assessments.
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing DT-101 with placebo for people with depression. Participants receive DT-101 or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with major depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether SPT-300 can help people with depression or depression With Anxious Distress. Participants take part in SPT-300 and complete follow-up assessments.
This study is looking at whether AXS-05 can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Low Dose PRT042 nasal spray with placebo for people with depression (depression. Participants receive Low Dose PRT042 nasal spray or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.